Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Armbrust and colleagues1 report a case of a child with restrictive dermopathy (RD) who had unusual symptoms: a transposition of the great arteries and a microcolon. The authors state that RD is an autosomal recessive disorder of unknown cause and suggest that the FATP4 gene is pathogenetically involved.
We were surprised by their article. The authors must have missed our recent articles2 - 3 in which we demonstrated that RD is caused either by mutations in the LMNA gene, encoding A-type lamins, or in the ZMPSTE24 gene, encoding a metalloprotease essential for the posttranslational processing of prelamin A to mature lamin A.2 - 3 As such, RD can be either autosomal dominant, as in the case of de novo splicing mutations in LMNA, or autosomal recessive, as in the case of loss of function mutations in ZMPSTE24.2 - 3 In the latter case, patients with these mutations have been found to be either homozygous or compound heterozygous.3 We have examined a total of 12 patients with RD and have identified mutations in all of them. Furthermore, major nuclear disorganization was observed, with accumulation of either truncated or normal-length prelamin A.2 - 3 Accumulation of lamin A precursors has a dramatically toxic effect on RD cells, as confirmed in recent studies4 performed on knockout mouse models for LMNA and ZMPSTE24. Our findings rule out mutations in the FATP4 gene as a potential cause for most cases of RD, despite the features resembling RD described in targeted disruption of FATP4 in mice.1 To date, the closest model for RD corresponds to the ZMPSTE24 knockout mouse.5 Thus, RD can be added to the group of laminopathies that consists of more than 10 different disorders. It most resembles the premature aging disorder progeria, which was previously associated with lamin A truncation.6
Studies of LMNA and ZMPSTE24 may still be possible in the patient reported by Armbrust and colleagues.1 Because their patient died after 24 days of life, which is somewhat unusual for patients with RD, the possibility exists that residual activity of the ZMPSTE24 gene is maintained together with mature lamin A or that a heterozygous mutation lies in the specific LMNA region encoding the lamin A isoform.
Their patient had symptoms that were unusual for RD. It may be possible that the heart defect in this child was related to the heart defect in her sibling and is in fact unrelated to the RD. Evaluation of the child’s sibling, perhaps using fluorescence in situ hybridization to search for a microdeletion of chromosome 22q11-13, seems warranted. Like the authors, we think these additional symptoms are unrelated to the RD. Finally, Armbrust et al1 mention that a uniparental disomy was identified in a sibling with Silver-Russell syndrome. We are not informed which chromosome was involved, but it may be useful to search for a similar molecular mechanism in the proband as well. The presence in a single family of various and different disorders pleads for extensive additional studies to explain this and to provide adequate genetic counseling for the parents.
Correspondence: Dr Levy, Genetique Medicale et Development, Faculté de Médécine de la INSERM U491, 13385 Marseille, CEDEX 05, France (Nicolas.Levy@medecine.univ-mrs.fr).
Financial Disclosure: None.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 7
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Sequencing the human genomeidentifying the entire sequence of base pairs in the 25 ...
Mutation
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.